Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a Home-Based exercise and relaxation program tame diabetes and Post-COVID stress?

NCT ID NCT05411458

Disease control Sponsor: Bozyaka Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a 12-week telerehabilitation program—combining aerobic walking and progressive relaxation exercises—can improve blood sugar control, stress, anxiety, and physical function in adults with type-2 diabetes, both with and without a prior COVID-19 infection. Participants will follow the program at home and be monitored remotely. The study aims to see if this approach can help manage diabetes and reduce the negative effects of COVID-19 on chronic disease.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 12-week telerehabilitation program combining aerobic walking and progressive relaxation exercises
What this could lead to
If effective, this program could offer a practical, home-based way to improve blood sugar control, stress, and anxiety in people with type-2 diabetes, especially those recovering from COVID-19.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply broadly. The program relies on self-reported exercise and may not be feasible for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Nov 2021

Finished

Nov 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1.Volunteer patients diagnosed with Type-2 DM by a specialist 2.18 to 65 years of age 3.To have control of comorbid diseases in the last 3 months 4.Not having any condition that prevents exercise 5.Voluntarily exercising three days a week Study group cases (for cases who have had Covid-19 Disease) in addition to the above-mentioned criteria; 1. Having had COVID-19 at least 1 time in the last 3 months 2. Having had COVID-19 at least 1 time in the last 3 months and survived the symptoms of the disease without mechanical ventilator support - Exclusion Criteria: 1. Having additional complications such as diabetic neuropathy, nephropathy, and retinopathy 2. Having a health problem (orthopedic, neurological, internal and cardiorespiratory) that prevents standing up / walking 3. no internet connection 4. malignancy, acute inflammation, intestinal tumor 5. Having cognitive impairment, vision and hearing loss that may interfere with working -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder COVID-19 type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID -19 Type 2 diabetes mellitus

Contacts and locations

Locations

  • Hayriye Yılmaz

    Izmir, 35110, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.